Pantoprazol Recordati (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Recordati, is a proton pump inhibitor presented as a strength/form for oral use. It reduces gastric acid secretion and is used to treat acid‑related disorders in adults and children. GNH USA supplies Pantoprazol Recordati as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazol Recordati as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Recordati is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive oesophagitis: accelerates mucosal healing and reduces further erosion. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with the condition. - Peptic ulcer disease: supports ulcer healing and prevents recurrence. - Helicobacter pylori eradication regimens (as part of combination therapy): enhances eradication success when used with antibiotics.

Pantoprazol Recordati is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually transient. - Nausea: occasional and self‑limiting. - Abdominal pain: mild discomfort. - Flatulence: excess gas. - Constipation: infrequent.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile infection: may present with watery diarrhoea. - Low magnesium levels (hypomagnesemia): can cause muscle cramps or cardiac arrhythmia. - Bone fracture risk: associated with long‑term use. - Acute interstitial nephritis: renal inflammation. - Liver enzyme elevation: may indicate hepatic stress.

When prescribing Pantoprazol Recordati, clinicians should consider several safety aspects.

- Assess risk of renal or hepatic impairment: dose adjustment may be needed. - Monitor for potential drug interactions: especially with drugs that require acidic pH for absorption. - Evaluate long‑term use implications: consider bone health assessment if therapy exceeds 1 year. - Use caution in pregnancy and breast‑feeding women : weigh the benefits against the potential risk to the fetus or infant. - Store at below 25°C: keep in the original pack , protect against moist  - 

Pantoprazole     

t   t  t  g   t.

t   t.

t  t  t.

ullet   t ullet ullet ullet ullet ullet.

ullet ullet ullet \\\n \